Mechanism // mechanism-hpg lens

Kisspeptin Mechanism of Action: The HPG Master Switch

How a single ligand docking on KISS1R becomes a GnRH pulse, an LH and FSH surge, and the downstream sex steroids.

Start here

The kisspeptin mechanism of action is, at heart, a relay. Picture a chain of command for reproduction. At the very top sits kisspeptin, a signaling molecule. It docks onto a receptor (a docking site called KISS1R, older name GPR54) on a set of nerve cells. That docking makes those nerve cells fire and release GnRH (gonadotropin-releasing hormone) in pulses. GnRH travels a short distance to the pituitary gland, which answers by releasing two hormones — LH and FSH — into the bloodstream. LH and FSH reach the ovaries or testes and switch on ovulation, sperm production, and the sex hormones. The key point is that kisspeptin does not supply any of those hormones itself. It only flips the switch at the top. Break the receptor, and the whole chain stays off — which is exactly what happens in people born without working KISS1R. The detail below traces each step of that relay.

The receptor and the second-messenger cascade

Kisspeptin binds KISS1R, a Gq/11-coupled G-protein-coupled receptor (GPCR) on hypothalamic GnRH neurons. Receptor activation drives a phospholipase C (PLC) cascade — the enzyme that splits a membrane lipid to make IP3 — which releases calcium from intracellular stores [2]. The resulting calcium signal closes potassium channels and opens non-selective cation channels, depolarizing the neuron. Experimentally, 100 nM kisspeptin depolarized GnRH neurons by 6 +/- 1 mV and raised firing rate by 87 +/- 4% in roughly 75% of adult GnRH neurons [2]. The receptor itself is the control point: kisspeptin fails to stimulate LH or FSH in Gpr54-knockout mice, and GPR54 transcripts co-localize with GnRH neurons, while central administration in sheep triggers GnRH release into cerebrospinal fluid with a parallel rise in serum LH [13].

From a GnRH pulse to LH, FSH, and the sex steroids

Once the GnRH neuron fires, the rest follows the HPG axis — the hypothalamic-pituitary-gonadal axis, the body's core reproductive control loop. Pulsatile GnRH stimulates the anterior pituitary to secrete LH (luteinizing hormone) and FSH (follicle-stimulating hormone), which then drive gonadal steroidogenesis: testosterone in men, estrogen and progesterone and ovulation in women. The proof that kisspeptin sits at the top of this loop is the human data — acute intravenous kisspeptin in healthy men potently increased LH and significantly raised FSH and testosterone [16] — and the genetics, where inactivating GPR54 mutations cause hypogonadotropic hypogonadism and failure of puberty [1]. Kisspeptin acts upstream on the body's own GnRH neurons; it does not itself supply LH, FSH, or sex steroids.

The KNDy pulse generator

The rhythm comes from the KNDy neurons of the arcuate nucleus — neurons co-expressing kisspeptin, neurokinin B, and dynorphin, thought to act as the GnRH pulse generator. In ewes, NK3-receptor signaling initiates synchronized KNDy activity, kappa-opioid (dynorphin) signaling terminates each burst, and kisspeptin relays the output to GnRH neurons [8]. A complementary population, the AVPV kisspeptin neurons, mediates the estradiol positive-feedback LH surge that drives ovulation, while the arcuate KNDy population handles negative feedback [9]. This two-population design is how one molecule can both set the steady reproductive baseline and trigger the ovulatory surge.

Two kisspeptin populations: baseline versus the surge

The mechanism has a second layer that explains how one molecule both maintains a steady reproductive baseline and triggers ovulation. Two anatomically distinct kisspeptin neuron populations do different jobs. The arcuate (ARC) KNDy population generates the pulsatile baseline and mediates the negative feedback by which sex steroids restrain the axis [9]. The anteroventral periventricular (AVPV) population mediates the estradiol positive-feedback LH surge that drives ovulation — rising estrogen, instead of suppressing this population, switches it on. A 2024 review further clarified the distinct AVPV-versus-ARC kisspeptin roles in the ovulatory surge [18]. So kisspeptin is not a single uniform signal: it is a two-channel system, one channel holding the tempo and the other firing the surge.

What kisspeptin is not: the conflation guard

Because kisspeptin sits in a crowded part of the reproductive cascade, it is easy to confuse with its neighbors — and the distinctions are mechanistically load-bearing. Kisspeptin is the ligand, the KISS1 gene product, acting on KISS1R. It is not GnRH, and it is not a GnRH agonist: it acts one rung above both, on the neurons that make GnRH [13]. It is not a sex hormone, and it does not supply LH, FSH, testosterone, or estrogen — it only triggers the body's own release of them upstream [1]. And it is not a dietary supplement, despite the search phrase: every documented human dose is an investigational protocol given under supervision [7]. Finally, the two research isoforms are distinct — kisspeptin-54 (KP-54, metastin) and the shorter kisspeptin-10 (KP-10) — sharing the receptor-binding RF-amide tail but differing in duration. Holding these apart is the difference between describing kisspeptin accurately and describing something it is not.

Why the mechanism sets a ceiling: receptor desensitization

The same mechanism that makes kisspeptin potent also limits it. Because the effect runs through a GPCR, sustained or high-dose activation downregulates KISS1R, and the response fades — tachyphylaxis. High-dose continuous infusion produced desensitization within the infusion itself [4], and twice-daily injection blunted the LH response over two weeks [14]. The mechanistic takeaway is that kisspeptin signaling is built for pulses, not floods: it is the upstream timer of a pulsatile system, and protocols that respect that rhythm preserve the response while continuous exposure exhausts it.